UBP product: Presentation of results at the Jahrestagung DGTI
Glycorex Transplantation AB (publ.), listed on NGM Main Regulated Equity, announces that the transfusion unit at the University Hospital of Regensburg today presents its first experience with the UBP-product as a poster at the Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunohämatologie (DGTI).The results are excellent even when exposing the UBP-product to stress, this by exposing it to larger plasma volumes and higher flow rates than what is recommended for the product. The results show that the UBP-product effectively lowers the level of blood group antibodies